Burton Enright Welch’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$674K Buy
4,596
+37
+0.8% +$6.71K 0.08% 81
2026
Q1
$671K Sell
4,559
-96
-2% -$15.6K 0.09% 77
2025
Q4
$907K Buy
4,655
+16
+0.3% +$3.81K 0.13% 65
2025
Q3
$1.3M Buy
4,639
+33
+0.7% +$8.4K 0.2% 55
2025
Q2
$1.01M Sell
4,606
-37
-0.8% -$5.97K 0.17% 55
2025
Q1
$649K Buy
4,643
+245
+6% +$39.9K 0.13% 56
2024
Q4
$733K Sell
4,398
-1
-0% -$178 0.15% 54
2024
Q3
$750K Sell
4,399
-86
-2% -$12.5K 0.16% 48
2024
Q2
$633K Hold
4,485
0.15% 49
2024
Q1
$563K Hold
4,485
0.14% 54
2023
Q4
$473K Buy
4,485
+243
+6% +$26.5K 0.13% 58
2023
Q3
$449K Buy
4,242
+1
+0% +$116 0.14% 54
2023
Q2
$505K Hold
4,241
0.16% 48
2023
Q1
$394K Buy
4,241
+618
+17% +$54.2K 0.15% 52
2022
Q4
$296K Buy
+3,623
New +$275K 0.12% 54
2022
Q3
Sell
-2,945
Closed -$206K 63
2022
Q2
$206K Buy
2,945
+1
+0% +$73 0.12% 61
2022
Q1
$244K Sell
2,944
-13
-0.4% -$1.05K 0.13% 58
2021
Q4
$258K Buy
+2,957
New +$278K 0.17% 53

Other funds holding ORCL

Burton Enright Welch's ORCL Position: Q2 2026 in Review

Burton Enright Welch increased its Oracle (ORCL) stake by 0.81% in Q2 2026, buying an estimated $6.71K and bringing the position to 4,596 shares worth $674K. The position accounts for 0.08% of the portfolio, ranked #81.

Burton Enright Welch first reported a position in ORCL in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.3M in Q3 2025. 3,511 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Burton Enright Welch held 4,596 shares of Oracle worth $674K as of Q2 2026.
  • Burton Enright Welch bought 37 Oracle shares in Q2 2026, an estimated $6.71K.
  • Oracle made up 0.08% of Burton Enright Welch's portfolio in Q2 2026, its #81 holding.
  • Burton Enright Welch first reported a position in Oracle in Q4 2021 and has held it in 18 quarters since.
  • Burton Enright Welch's Oracle position peaked at $1.3M in Q3 2025.
  • 3,511 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Burton Enright Welch's 13F filing for Q2 2026, filed 17 Jul 2026.